Polymer gel containing hyaluronic acid and collagen, and its use in joints
View Patent ↗Formulations and methods for treating joints, such as temporomandibular joint disorders, osteoarthritis of the knee, hip and other types of inflammatory joint diseases. The method involves identifying specific matrix metalloproteinases (MMPs) that may be responsible for degrading the soft tissues of the joint in question, identifying the specific component of the joint the MMP(s) are targeting, and injecting a polymer gel with the component the MMP(s) seek to destroy, thus preserving the joint and allowing time to heal. These formulations typically require a mixture of glycosoaminoglycans and collagen proteins. One formulation in particular includes both hyaluronic acid and at least type I collagen.
1. A gel formulation to treat temporomandibular joint (TMJ) disorders comprising approximately 1.5% hyaluronic acid, and approximately 1.5% total collagen comprising type I and type III collagen, approximately 96% water, and approximately 0.9% NaCl, wherein the formulation has a viscosity of about 6476 centipoise (cP).
2. The formulation of claim 1 , wherein the hyaluronic acid is of a high molecular weight of more than one million Daltons.
3. A method of treating a joint comprising placing into the joint the formulation of claim 1 .
4. The method of claim 3 wherein the formulation is placed into the joint by injection.
5. A method for treating joint pain, in which inflammatory cytokines are present in the joint at elevated levels, comprising:
(i) identifying one or more inflammatory cytokines present in the joint at elevated levels;
(ii) determining one or more resulting matrix metalloproteinase (MMP) enzymes present in the joint;
(iii) preparing a polymer gel according to the formulation of claim 1 , comprising one or more substrates that said MMP enzymes are active against; and
(iv) placing the polymer gel into the joint.